CytomX Therapeutics (CTMX) Reports revenue
Tweet
Share
E-mailGet Alerts CTMX Hot Sheet
Join SI Premium – FREE
CytomX Therapeutics (NASDAQ: CTMX) reportedrevenue for the quarter came in at $26.6 million versus the consensus estimate of $19.6 million.
For earnings history and earnings-related data on CytomX Therapeutics (CTMX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CytomX Therapeutics (CTMX) PT Lowered to $14 at Guggenheim
- Park Dental Partners, Inc. (PARK) Tops Q2 EPS by 28c
- Southland Holdings (SLND) Misses Q2 EPS by 122c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
